The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AERIE PHARMACEUTICALS INC NOTE 1.500%10/0 00771VAB4 2,931 3,675,000 SH   SOLE   3,675,000 0 0
AKAMAI TECHNOLOGIES INC NOTE 0.375% 9/0 00971TAL5 20,246 17,500,000 SH   SOLE   17,500,000 0 0
BENTLEY SYS INC COM CL B 08265T208 785 25,000 SH   SOLE   25,000 0 0
HUMANIGEN INC COM NEW 444863203 8,778 825,000 SH   SOLE   825,000 0 0
IAC INTERACTIVECORP NEW COM 44891N109 21,407 178,722 SH   SOLE   178,722 0 0
MATCH GROUP INC NEW COM 57667L107 86,821 784,643 SH   SOLE   784,643 0 0
PINDUODUO INC NOTE 10/0 722304AB8 456 250,000 SH   SOLE   250,000 0 0
RENALYTIX AI PLC ADS 75973T101 1,219 100,000 SH   SOLE   100,000 0 0
SNAP INC NOTE 0.750% 8/0 83304AAB2 16,613 12,000,000 SH   SOLE   12,000,000 0 0
SUMMIT THERAPEUTICS INC COM 86627T108 17,200 5,000,000 SH   SOLE   5,000,000 0 0
VERTEX INC CL A 92538J106 2,783 121,000 SH   SOLE   121,000 0 0